(4-(4-Chloro-1H-pyrazol-1-yl)phenyl)methanamine

Catalog No.: 
ACUIGS267
CAS No.: 
1006442-29-0
Molecular Formula: 
C10H10ClN3
Molecular Weight: 
207.66
(4-(4-Chloro-1H-pyrazol-1-yl)phenyl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$63.00In stockInquiry
1g97%$168.00In stockInquiry
5g97%$538.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-(4-Chloro-1H-pyrazol-1-yl)phenyl)methanamine
IUPAC Name(4-(4-chloro-1H-pyrazol-1-yl)phenyl)methanamine
Molecular FormulaC10H10ClN3
Molecular Weight207.66
SMILESNCC1=CC=C(N2N=CC(Cl)=C2)C=C1
InChI KeyRRPBVAZFGFIHSP-UHFFFAOYSA-N
Synonym1-[4-(4-chloro-1H-pyrazol-1-yl)phenyl]methanamine;(4-(4-Chloro-1H-pyrazol-1-yl)phenyl)methanamine;Benzenemethanamine, 4-(4-chloro-1H-pyrazol-1-yl)-
CAS No.1006442-29-0

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H315-H318-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338+P310-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACUIGS267 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUIGS267 route product structure diagram
    ACUIGS2671006442-29-0In Stock
Inquiry

2. ACUIGS267 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUIGS267 route product structure diagram
    ACUIGS2671006442-29-0In Stock
Inquiry

3. ACUIGS267 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUIGS267 route product structure diagram
    ACUIGS2671006442-29-0In Stock
Inquiry

Comments (0)